Cargando…

Immunosuppressants/voriconazole: COVID-19 infection, invasive systemic aspergillosis and visual disturbance: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285683/ http://dx.doi.org/10.1007/s40278-021-99122-7

Ejemplares similares

Voriconazole-refractory invasive aspergillosis
por: Park, Se Yoon, et al.
Publicado: (2017)

Voriconazole: Lack of efficacy during treatment of invasive pulmonary aspergillosis: 2 case reports
Publicado: (2021)

Invasive maxillary sinus aspergillosis: A case report successfully treated with voriconazole and surgical debridement
por: Peral-Cagigal, Beatriz, et al.
Publicado: (2014)

Dexamethasone/voriconazole: Invasive aspergillosis following off-label use; lack of efficacy: case report
Publicado: (2022)

Dexamethasone/voriconazole: Invasive pulmonary aspergillosis secondary to Aspergillus terreus and treatment failure: case report
Publicado: (2021)

Voriconazole-Induced Hepatotoxicity in a Patient with Pulmonary Aspergillosis: A Case Report
por: Gu, Li, et al.
Publicado: (2023)

Posaconazole achieves prompt recovery of voriconazole-induced liver injury in a case of invasive aspergillosis
por: Martínez-Casanova, Javier, et al.
Publicado: (2018)

Semi-invasive pulmonary aspergillosis in an immunosuppressed patient: a case report
por: Cabral, Fernanda C, et al.
Publicado: (2009)

Management of invasive aspergillosis in patients with COPD: Rational use of voriconazole
por: Ader, Florence, et al.
Publicado: (2009)

Triple infection with disseminated tuberculosis, invasive aspergillosis and COVID-19 in an organ transplant recipient with iatrogenic immunosuppression
por: Vidanapathirana, Manudi, et al.
Publicado: (2021)

Pharmacology and metabolism of voriconazole and posaconazole in the treatment of invasive aspergillosis-review of the literature
por: Sandherr, M, et al.
Publicado: (2011)

Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin - review of the literature
por: Karthaus, M
Publicado: (2011)

A suspected case of autoinduction of voriconazole metabolism in a patient with cerebral aspergillosis
por: Ferguson, Martin J, et al.
Publicado: (2017)

Azithromycin/dexamethasone/voriconazole: Pulmonary aspergillosis following off-label use, and lack of efficacy: case report
Publicado: (2021)

Orbital Aspergillosis: Voriconazole – The New Standard Treatment?
por: Ohlstein, Derek H., et al.
Publicado: (2012)

Economic considerations in the treatment of invasive aspergillosis: a review of voriconazole pharmacoeconomic studies
por: Krueger, Kem P, et al.
Publicado: (2009)

An observational efficacy and safety analysis of the treatment of acute invasive aspergillosis using voriconazole
por: Jacobs, F., et al.
Publicado: (2011)

Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in Spain
por: Grau, Santiago, et al.
Publicado: (2016)

Convalescent-anti-SARS-CoV-2-plasma/dexamethasone/voriconazole: Invasive pulmonary aspergillosis, off label use and lack of efficacy: case report
Publicado: (2021)

Voriconazole Induced Hallucinations and Visual Disturbances in a Female Child: A Case Report and Literature Review
por: Zheng, Rujiang, et al.
Publicado: (2021)

Cost-Effectiveness Analysis of Isavuconazole vs. Voriconazole as First-Line Treatment for Invasive Aspergillosis
por: Harrington, Rachel, et al.
Publicado: (2016)

Short course of voriconazole therapy as a risk factor for relapse of invasive pulmonary aspergillosis
por: Shin, Dong Hoon, et al.
Publicado: (2020)

Immunosuppressants/Antifungals: COVID-19 associated mucormycosis, COVID-19 associated pulmonary aspergillosis and lack of efficacy: case report
Publicado: (2022)

Therapeutic Drug Monitoring of Sputum Voriconazole in Pulmonary Aspergillosis
por: Sarfati, Sacha, et al.
Publicado: (2022)

Amphotericin-b/dexamethasone/voriconazole: Palatal mucormycosis, neutropenia and electrolyte disturbance: 2 case reports
Publicado: (2022)

Post covid-19 invasive pulmonary Aspergillosis: A case report
por: Kakamad, Fahmi H., et al.
Publicado: (2021)

Safety, Efficacy, and Exposure–Response of Voriconazole in Pediatric Patients With Invasive Aspergillosis, Invasive Candidiasis or Esophageal Candidiasis
por: Martin, Judith M., et al.
Publicado: (2017)

Poststernotomy aspergillosis: successful treatment with voriconazole, surgical debridement and vacuum-assisted closure therapy
por: Siciliano, Rinaldo Focaccia, et al.
Publicado: (2012)

Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden
por: Floros, Lefteris, et al.
Publicado: (2019)

1147. Short Course of Voriconazole Therapy as a Risk Factor for Relapse of Invasive Pulmonary Aspergillosis
por: Shin, Dong Hoon, et al.
Publicado: (2020)

Voriconazole: Hepatotoxicity: case report
Publicado: (2021)

Toward the personalized and integrative management of voriconazole dosing during COVID-19-associated pulmonary aspergillosis
por: Le Daré, Brendan, et al.
Publicado: (2021)

Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial
por: Cadranel, J., et al.
Publicado: (2012)

CNS aspergillosis in a patient with Crohn’s disease on immunosuppressants: a case report
por: Shah, Shreyansh, et al.
Publicado: (2009)

Role of Voriconazole in the Management of Invasive Central Nervous System Aspergillosis: A Case Series from a Tertiary Care Centre in India
por: Gupta, Nitin, et al.
Publicado: (2020)

Invasive pulmonary aspergillosis complicating COVID-19 in the ICU - A case report
por: Prattes, Juergen, et al.
Publicado: (2020)

Immunosuppressants: COVID-19 infection: case report
Publicado: (2022)

Pharmacokinetic and Exposure Response Analysis of the Double-Blind Randomized Study of Posaconazole and Voriconazole for Treatment of Invasive Aspergillosis
por: Maertens, Johan A., et al.
Publicado: (2023)

Post‐COVID‐19 co‐morbidity of emerged Lophomonas infection and invasive pulmonary aspergillosis: First case report
por: Sharifpour, Ali, et al.
Publicado: (2021)

Orbital Apex Syndrome caused by invasive aspergillosis in patient with post-Covid-19 infection - A case report
por: Lama, Manik Kumar, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j55e6pu1d25n1mh839ve535tle